These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7347383)

  • 21. Cerebral oligodendrogliomas. Clinical manifestations, surgical treatment and histological findings in seventy cases.
    Wislawski J
    Pol Med J; 1970; 9(1):163-72. PubMed ID: 4985390
    [No Abstract]   [Full Text] [Related]  

  • 22. Supratentorial recurrences of gliomas. Tissue culture studies with astrocytomas and oligodendrogliomas.
    Gazsó L; Afra D; Müller W
    Acta Neuropathol; 1978 Nov; 44(2):135-9. PubMed ID: 716841
    [No Abstract]   [Full Text] [Related]  

  • 23. [Advances in diagnosis and treatment of oligodendrogliomas of the brain. Eighty-four surgical patients (author's transl)].
    Paillas JE; Grisoli F; Hassoun J; Torres-Garcia T; De Laforte C
    Sem Hop; 1982 Apr; 58(14):851-6. PubMed ID: 6281897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain scanning in oligodendrogliomas: a detailed neuropathology-scan correlation of 34 histologically verified cases.
    Schall GL; Heffner RR; Handmaker H
    Radiology; 1975 Aug; 116(02):367-72. PubMed ID: 1153739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathology of malignant gliomas.
    Bruner JM
    Semin Oncol; 1994 Apr; 21(2):126-38. PubMed ID: 8153659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An operative series of 27 cases of oligodendrogliomas].
    Lloret J; Argüello C; Gutiérrez M; Manrique M; Blazquez MG
    Rev Esp Otoneurooftalmol Neurocir; 1979 Mar; 37(206):4-5. PubMed ID: 461923
    [No Abstract]   [Full Text] [Related]  

  • 28. Proliferative activity of chosen central nervous system (CNS) neoplasms.
    Lebelt A; Szkudlarek M; Guzińska-Ustymowicz K; Lemancewicz D; Zimnoch L; Dziecioł J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():242-3. PubMed ID: 15638437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral midline tumours involving the corpus callosum (tumours of the tapetum).
    Selecki BR; Lethlean AK
    Med J Aust; 1970 Dec; 2(23):1069-71. PubMed ID: 5491079
    [No Abstract]   [Full Text] [Related]  

  • 30. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.
    Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ
    Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
    Hasselblatt M; Paulus W
    Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RhoA protein expression correlates positively with degree of malignancy in astrocytomas.
    Yan B; Chour HH; Peh BK; Lim C; Salto-Tellez M
    Neurosci Lett; 2006 Oct; 407(2):124-6. PubMed ID: 16978776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics of oligodendrogliomas of the brain in the age aspect].
    Malikov AI
    Vrach Delo; 1980 May; (5):77-9. PubMed ID: 7395172
    [No Abstract]   [Full Text] [Related]  

  • 34. Qualitative and quantitative analysis of cytologic assessment of astrocytoma, oligodendroglioma and oligoastrocytoma.
    Inagawa H; Ishizawa K; Hirose T
    Acta Cytol; 2007; 51(6):900-6. PubMed ID: 18077983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
    Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
    Perry A; Aldape KD; George DH; Burger PC
    Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
    Gajewicz W; Papierz W; Szymczak W; Goraj B
    Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial angiogliomas.
    Shuangshoti S; Panyathanya R
    J Med Assoc Thai; 1983 Dec; 66(12):799-811. PubMed ID: 6676444
    [No Abstract]   [Full Text] [Related]  

  • 40. [Astrocytoma and astroblastoma].
    Sano K
    No To Shinkei; 1969 Jun; 21(6):610-3. PubMed ID: 5820332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.